|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 116.36 EUR | +0.52% |
|
+2.61% | +9.65% |
| 08-11 | Global drugmakers invest billions to boost US presence | RE |
| 08-05 | Gilead Sciences Delivers 'Plenty' to Like in Q2, RBC Says | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | Other Pharmaceuticals | +0.52% | +2.61% | +9.65% | +13.81% | +93.55% | 165B |
-
|
-
|
-
|
- Stock Market
- Stocks
- GILD Stock
- GILD Stock
- Charts Gilead Sciences, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
